Superior Cluneal Nerve Block: Can This Injection Relieve Chronic Low Back Pain?

Chronic low back pain can be frustrating, particularly when magnetic resonance imaging shows only mild degenerative changes, physical therapy provides limited improvement, and repeated treatments fail to identify the actual source of discomfort. For some patients, the problem may not originate in the spinal discs, vertebrae, or facet joints. Instead, a small sensory nerve crossing the upper border of the pelvis may be responsible.

The superior cluneal nerve is one of several nerves that provide sensation to the lower back and upper buttock region. When this nerve becomes irritated or compressed, it can produce persistent pain around the posterior iliac crest, sometimes extending into the buttock or thigh. Because these symptoms overlap with more familiar spinal conditions, superior cluneal nerve entrapment is frequently overlooked.

A superior cluneal nerve block is a minimally invasive injection used to investigate whether this nerve is contributing to chronic low back pain. In selected patients, the injection may also provide meaningful pain relief.

However, an important question remains: If a superior cluneal nerve block relieves the pain, does that mean the problem is permanently resolved?

The answer depends on the underlying cause of nerve irritation, the response to the injection, and whether additional treatment is necessary.

Understanding how the procedure works, what results to expect, and what happens when the pain returns can help patients make more informed decisions about managing chronic low back pain.

A superior cluneal nerve block is an injection of local anesthetic, sometimes combined with a corticosteroid, around one or more branches of the superior cluneal nerve.

The injection temporarily interrupts pain signals traveling through the targeted nerve.

Unlike an epidural steroid injection, which delivers medication into the epidural space surrounding spinal nerve roots, a superior cluneal nerve block targets a superficial sensory nerve near the posterior iliac crest.

The procedure serves two purposes.

Diagnostic purpose: If the patient’s familiar pain decreases substantially after the injection, it provides evidence that the superior cluneal nerve may be contributing to the symptoms.

Therapeutic purpose: The injection may reduce pain for a period of time, allowing the patient to move more comfortably, participate in rehabilitation, and perform everyday activities.

The superior cluneal nerves are purely sensory nerves. They do not directly control leg muscle strength, which is one reason their entrapment can produce considerable pain without the typical motor weakness associated with certain spinal nerve root disorders.

Research has identified superior cluneal nerve entrapment as a potentially treatable source of chronic low back pain, particularly in patients with tenderness along the posterior iliac crest.

The superior cluneal nerves arise primarily from the dorsal branches of the upper lumbar spinal nerves, although their precise anatomical origins vary between individuals.

These small nerves travel through the muscles and connective tissues of the lower back before crossing the iliac crest to supply sensation to the upper buttock region.

As the nerves approach the iliac crest, certain branches pass through the thoracolumbar fascia. Some travel through narrow fibrous or osteofibrous tunnels, where they may become compressed.

This compression can irritate the nerve and produce localized or radiating pain.

Several factors may contribute to irritation or entrapment of the superior cluneal nerve.

These include:

• Thickening or tightening of the thoracolumbar fascia.
• Repetitive bending, twisting, or prolonged mechanical stress.
• Previous lumbar spine surgery.
• Scar tissue formation around the nerve.
• Anatomical variations in the course of the nerve.
• Changes in spinal alignment or posture.
• Trauma involving the lower back or pelvic region.
• Degenerative spinal conditions that alter movement patterns.

In some patients, no single cause can be identified.

Superior cluneal nerve entrapment may also coexist with lumbar disc degeneration, facet joint arthritis, or sacroiliac joint dysfunction. This can make identifying the primary source of pain particularly challenging.

A review published in Neurospine reported that superior cluneal nerve entrapment had been identified in approximately 1.6% to 14% of patients evaluated for low back pain across different studies. The wide range reflects differences in patient populations and diagnostic methods.

Not every patient with chronic low back pain is a suitable candidate for a superior cluneal nerve block.

The procedure is generally considered when the patient’s symptoms and physical examination suggest irritation of the superior cluneal nerve.

One of the most characteristic symptoms is pain over the posterior iliac crest.

Patients may describe the discomfort as aching, burning, stabbing, or unusually sensitive to pressure.

The pain may be concentrated on one side of the lower back, although bilateral involvement is possible.

Superior cluneal nerve entrapment can produce pain extending from the lower back into the buttock.

Some patients also experience symptoms radiating into the thigh or farther down the leg.

This pattern can resemble lumbar radiculopathy, commonly called sciatica, even though the underlying mechanism is different.

Symptoms may increase during activities such as:

• Walking for extended periods.
• Standing for prolonged periods.
• Bending forward or backward.
• Twisting the lower back.
• Rising from a seated position.
• Performing repetitive lifting activities.

However, these symptoms are not specific to superior cluneal nerve entrapment and can occur with several other musculoskeletal conditions.

A particularly useful clinical finding is tenderness over the posterior iliac crest where the superior cluneal nerve crosses the fascia.

Pressing this area may reproduce the patient’s familiar pain or cause tingling and radiating discomfort.

This response is sometimes described as a Tinel-like sign.

When characteristic symptoms, localized tenderness, and pain relief following a targeted nerve block occur together, the diagnosis becomes more convincing.

Chronic low back pain has numerous possible causes, and treatment should be directed toward the structure most likely responsible for the symptoms.

For example, an epidural steroid injection may be considered for selected patients with inflammation or irritation involving a spinal nerve root.

A lumbar medial branch block is used to investigate pain arising from the facet joints.

A sacroiliac joint injection targets pain associated with the sacroiliac joint.

A superior cluneal nerve block, by comparison, targets a sensory nerve traveling across the posterior iliac crest.

These procedures are not interchangeable.

A patient who has received an epidural injection without meaningful improvement may still have pain originating from the superior cluneal nerve. Conversely, a patient with true lumbar nerve root compression may receive little benefit from a cluneal nerve block.

This distinction becomes especially important when imaging findings do not adequately explain the patient’s symptoms.

Magnetic resonance imaging can identify many spinal abnormalities, but it generally cannot reliably demonstrate entrapment of these very small peripheral nerves.

Consequently, the diagnosis often depends on the clinical examination and response to a targeted diagnostic injection.

A superior cluneal nerve block is usually performed as an outpatient procedure.

The exact technique depends on the physician’s experience, the patient’s anatomy, and whether ultrasound guidance is used.

Before the injection, the physician reviews the patient’s symptoms and examines the lower back.

Particular attention is given to tenderness along the posterior iliac crest.

The physician may press different locations to identify the point that reproduces the patient’s typical pain.

The patient may also be asked to rate the pain before the procedure so that the response can be evaluated afterward.

The patient generally lies face down on an examination or procedure table.

The skin over the lower back and upper pelvic region is exposed and cleaned with an antiseptic solution.

The physician identifies the appropriate anatomical landmarks.

The superior cluneal nerve can be targeted using anatomical landmarks or imaging guidance.

Ultrasound-guided superior cluneal nerve block is increasingly described in the medical literature because ultrasound allows the physician to visualize relevant muscles, fascia, bony landmarks, and nearby soft tissues.

With suitable equipment and technique, some branches of the nerve may also be identified.

Ultrasound can help guide needle placement and observe the spread of medication around the intended area.

However, visualization is not always possible because the nerve branches are extremely small and their anatomical course varies.

A 2024 narrative review in the Journal of Pain Research examined several ultrasound-guided approaches and concluded that ultrasound is useful for guiding superior cluneal nerve injections, although more research is needed to establish the optimal technique and medication volume.

Once the target area has been identified, the physician advances a fine needle toward the appropriate tissue plane.

A local anesthetic is injected around the suspected nerve.

Depending on the clinical situation, a corticosteroid may also be administered.

Commonly used local anesthetics include lidocaine and bupivacaine.

The choice of medication, concentration, and injection volume varies according to the physician’s assessment and the purpose of the block.

The patient may experience temporary pressure, mild discomfort, or a brief stinging sensation during the injection.

After the injection, the patient is observed for any immediate adverse reactions.

The physician may ask the patient to repeat movements that previously triggered the pain.

For example, the patient may be asked to stand, walk, bend, or gently rotate the lower back.

A substantial reduction in familiar pain during the expected anesthetic period supports the possibility that the superior cluneal nerve is contributing to the symptoms.

The injection itself generally takes only a short time, although preparation, assessment, and post-procedure monitoring extend the overall appointment.

Most patients experience some discomfort during needle insertion, but the procedure is generally well tolerated.

The injection may cause a brief stinging or burning sensation, particularly when the medication enters the tissues surrounding the nerve.

Because the target is relatively superficial compared with deeper spinal structures, the procedure does not require the needle to enter the spinal canal.

However, pain tolerance varies, and patients with marked sensitivity around the iliac crest may find the injection uncomfortable.

Mild soreness at the injection site can occur afterward.

The physician may recommend applying a cold pack for short periods if local tenderness develops.

Severe or progressively worsening pain is not an expected response and should be reported.

The effectiveness of a superior cluneal nerve block depends heavily on whether the superior cluneal nerve is actually responsible for the patient’s pain.

Patients with characteristic tenderness and a positive diagnostic response may experience meaningful improvement.

However, the available research does not establish a single reliable success rate that applies to every patient.

A review published in Neurospine summarized studies evaluating superior cluneal nerve blocks for low back pain.

In one study discussed in the review, approximately 68% of patients experienced more than 50% pain relief after one to three superior cluneal nerve blocks.

Other studies reported less favorable results, demonstrating that treatment outcomes vary considerably.

A comprehensive review published in 2022 also identified nerve blocks as an important diagnostic and therapeutic option for cluneal neuralgia.

The authors noted that patients who respond favorably may benefit from additional conservative or interventional treatments when necessary.

More recently, a 2024 review of ultrasound-guided superior cluneal nerve blocks found encouraging clinical results but emphasized that much of the available evidence comes from relatively small studies, case series, and observational reports.

Large, well-designed randomized clinical trials remain limited.

Therefore, a superior cluneal nerve block should be viewed as a targeted diagnostic and potentially therapeutic intervention rather than a guaranteed cure for chronic low back pain.

One of the most common questions patients ask is how long the injection will relieve their pain.

Unfortunately, there is no fixed duration.

The response depends on several factors, including the medication used, the degree of nerve irritation, the presence of ongoing compression, and whether other structures are contributing to the pain.

Local anesthetic medication temporarily interrupts nerve signaling.

Depending on the anesthetic, pain relief may begin within minutes and continue for several hours.

This immediate response is particularly useful when the injection is intended to confirm the source of pain.

If the patient’s familiar low back pain improves substantially during this period, it supports the involvement of the targeted nerve.

Some patients experience improvement extending beyond the expected duration of the local anesthetic.

When corticosteroids are used, their anti-inflammatory effects may contribute to longer-lasting relief.

However, the additional benefit of corticosteroids specifically for superior cluneal nerve blocks has not been firmly established.

A smaller proportion of patients may experience sustained improvement after one or more injections.

This may occur when temporary pain reduction allows improved movement, decreased protective muscle guarding, and more effective rehabilitation.

Nevertheless, prolonged relief should not be assumed.

If the nerve remains mechanically compressed, symptoms may eventually return.

A successful nerve block can provide valuable information beyond temporary pain relief.

The next step depends on the duration of improvement and whether the patient can return to normal activities.

When the injection produces meaningful and sustained improvement, the physician may recommend continued observation.

Physical therapy, activity modification, and gradual strengthening may help maintain function.

The goal is to avoid unnecessary additional procedures while addressing mechanical factors that could aggravate the nerve.

Temporary relief followed by recurrence can still be clinically useful.

It suggests that the targeted nerve may be contributing to the pain, even though the injection has not permanently corrected the underlying problem.

The physician may consider repeating the block or discussing other treatment options.

However, repeated injections are not automatically appropriate for every patient.

The decision depends on the magnitude and duration of benefit, medication exposure, overall health, and alternative explanations for the pain.

Partial improvement may indicate that the superior cluneal nerve is one of several pain generators.

For example, a patient may have both superior cluneal nerve entrapment and lumbar facet joint arthritis.

In this situation, treatment may need to address more than one source of discomfort.

A lack of improvement may suggest that the superior cluneal nerve is not the primary source of pain.

However, it does not completely exclude nerve involvement.

Technical factors, anatomical variations, incomplete medication spread, and overlapping pain conditions may influence the result.

The physician should reassess the diagnosis rather than automatically proceeding with repeated injections.

When a superior cluneal nerve block provides only temporary relief, several additional treatments may be considered.

The most appropriate option depends on the patient’s symptoms, diagnostic findings, previous treatments, and functional limitations.

Physical therapy may help address movement restrictions, muscle weakness, and mechanical factors that contribute to persistent low back pain.

Treatment may focus on:

• Improving lumbar and pelvic mobility.
• Strengthening the abdominal and hip muscles.
• Reducing excessive strain during bending and lifting.
• Correcting aggravating movement patterns.
• Gradually increasing walking and activity tolerance.

Physical therapy does not necessarily release a mechanically entrapped nerve, but it may improve function and reduce associated musculoskeletal pain.

Exercises should be individualized because aggressive stretching or direct pressure over the painful area may aggravate symptoms in some patients.

A repeat injection may be considered when the initial block produces substantial relief but symptoms subsequently return.

The physician should evaluate how long the improvement lasted and whether the patient experienced meaningful functional benefits.

Repeated corticosteroid injections also require consideration of cumulative medication exposure and potential adverse effects.

There is no universally accepted injection schedule specifically for superior cluneal nerve entrapment.

Radiofrequency ablation is a minimally invasive procedure that uses radiofrequency energy to alter pain signaling in targeted nerve tissue.

For patients who experience substantial but temporary relief from a diagnostic nerve block, radiofrequency treatment may be considered.

Different techniques have been described, including conventional thermal radiofrequency treatment and pulsed radiofrequency approaches.

These methods are not identical.

Conventional radiofrequency treatment produces a thermal lesion, while pulsed radiofrequency generally uses lower temperatures and aims to modify nerve signaling without producing the same degree of thermal destruction.

The goal is to provide longer-lasting pain reduction than a temporary anesthetic block.

However, evidence supporting radiofrequency treatment specifically for superior cluneal nerve pain remains limited, and there is no universally established treatment protocol.

A 2024 discussion of superior cluneal neuralgia identified radiofrequency procedures as a possible next step in carefully selected patients who obtain temporary relief from diagnostic blocks.

Peripheral nerve stimulation is another potential option for patients with persistent superior cluneal nerve pain.

This treatment uses small electrical impulses delivered near the affected nerve to modify pain signaling.

Depending on the system, electrodes may be placed near the nerve and connected to an external or implanted stimulation device.

Peripheral nerve stimulation may be considered when conservative treatment and injections have failed to provide adequate relief.

However, the evidence for superior cluneal nerve stimulation remains limited, and treatment availability, eligibility, and insurance coverage vary.

Surgical decompression may be considered in selected patients with persistent symptoms and convincing evidence of nerve entrapment.

During the procedure, the surgeon attempts to release the nerve from surrounding tissues that are compressing it.

This may involve opening restrictive fascial structures or releasing fibrous tissue around the nerve.

Surgery is generally reserved for patients who have not obtained adequate improvement with less invasive treatments.

Although published surgical series have reported favorable outcomes in selected patients, these findings should be interpreted cautiously because many studies involve small populations and lack direct comparisons with nonsurgical treatment.

A comprehensive review of cluneal neuralgia describes surgical decompression as an option for carefully selected patients with persistent symptoms.

A superior cluneal nerve block is generally considered a relatively low-risk procedure when performed by an appropriately trained clinician.

Nevertheless, no injection is completely free of complications.

Patients may experience:

• Mild soreness at the injection site.
• Temporary bruising.
• Localized tenderness.
• Temporary numbness over the upper buttock.
• A short-lived increase in pain after the injection.

These symptoms usually improve without additional treatment.

Potential complications include infection, bleeding, allergic reactions, injury to nearby tissues, and nerve damage.

Accidental injection of local anesthetic into a blood vessel can cause systemic toxicity, although this is uncommon.

Symptoms of local anesthetic toxicity may include unusual dizziness, ringing in the ears, metallic taste, confusion, seizures, or cardiovascular disturbances.

If corticosteroids are included, temporary elevation of blood glucose and other steroid-related effects may occur.

Ultrasound guidance may help clinicians identify relevant anatomy and monitor needle placement, but it does not eliminate every procedural risk.

Patients should inform their physician about allergies, anticoagulant medications, diabetes, active infections, and previous adverse reactions to injections.

Post-procedure instructions vary depending on the medication used and the physician’s protocol.

Most patients can return home after a brief observation period.

However, strenuous activity may need to be limited for the remainder of the day.

Patients should follow the treating clinician’s instructions regarding driving, exercise, bathing, and medication use.

A pain diary can be particularly valuable after a diagnostic superior cluneal nerve block.

Patients should record their pain level before the injection and at several intervals afterward.

It is also helpful to document changes in activities that previously caused discomfort.

For example, a patient who could stand for only ten minutes before the injection may find that standing becomes more comfortable afterward.

These functional changes can be just as important as the numerical pain score.

Although the physician may recommend repeating familiar movements to assess the response, patients should avoid excessive bending, lifting, or exercise simply because the pain has temporarily improved.

Local anesthetic can reduce pain perception without correcting the underlying mechanical problem.

Patients should contact their healthcare provider if they develop increasing redness, swelling, drainage, fever, persistent numbness, or progressively worsening pain after the injection.

Severe allergic symptoms, breathing difficulties, seizures, or other serious reactions require emergency medical attention.

Yes, in appropriately selected patients.

One reason superior cluneal nerve entrapment can remain undiagnosed is that routine lumbar magnetic resonance imaging does not reliably demonstrate the condition.

The superior cluneal nerves are small peripheral sensory nerves, and compression may occur where they pass through fascia near the iliac crest.

Standard lumbar imaging is primarily designed to evaluate spinal structures rather than these superficial nerve branches.

Therefore, a patient may have persistent pain despite imaging that does not reveal a convincing spinal explanation.

However, normal imaging does not automatically mean that the superior cluneal nerve is responsible.

Other causes, including myofascial pain, sacroiliac joint dysfunction, hip disorders, and certain spinal pain conditions, may also be present.

A targeted physical examination and carefully interpreted diagnostic block are important.

Although both procedures may be used in patients with low back pain, they target different anatomical structures.

An epidural steroid injection delivers medication into the epidural space surrounding the spinal nerve roots.

It is generally considered when symptoms suggest certain forms of spinal nerve root irritation, particularly radicular pain.

A superior cluneal nerve block targets a peripheral sensory nerve near the posterior iliac crest.

It is considered when localized tenderness and the pain pattern suggest superior cluneal nerve entrapment.

A patient with a lumbar disc herniation causing nerve root compression may be more likely to benefit from treatment directed toward that condition.

A patient whose primary pain originates from the superior cluneal nerve may benefit more from a targeted cluneal nerve injection.

Importantly, both conditions can coexist.

The decision should be based on the patient’s history, examination findings, and diagnostic evaluation rather than imaging alone.

Yes.

Superior cluneal nerve entrapment has been described in patients with persistent or recurrent low back pain following lumbar spine surgery.

Such patients may continue experiencing discomfort even when postoperative imaging does not identify a clear surgical complication.

Scar tissue, altered movement patterns, or preexisting nerve entrapment may contribute to symptoms.

In some cases, superior cluneal nerve pain may have been present before the original spinal operation but was not recognized.

However, persistent pain after spine surgery has many possible causes, including recurrent spinal pathology, nerve root problems, adjacent segment disease, and other musculoskeletal conditions.

A superior cluneal nerve block may be useful when the examination reveals characteristic tenderness along the posterior iliac crest.

The possibility of cluneal nerve entrapment in patients with persistent pain after lumbar surgery has been discussed in the clinical literature.

No.

A trigger point injection generally targets a painful area within a muscle or associated soft tissue.

A superior cluneal nerve block specifically targets the sensory nerve believed to be producing the pain.

Although both injections may be performed near a tender point, their intended anatomical targets and diagnostic purposes differ.

There is no universally accepted number of injections suitable for every patient.

Some patients improve after a single injection, while others may undergo additional blocks.

The physician considers the degree of relief, duration of improvement, medications used, and potential risks before recommending another procedure.

Yes.

A nerve block may temporarily interrupt pain signals without permanently relieving mechanical compression.

If the underlying irritation continues, symptoms can return after the medication wears off.

A successful temporary response may help guide further treatment.

A substantial reduction in the patient’s familiar pain supports the diagnosis of superior cluneal nerve-mediated pain.

However, a single positive block does not provide absolute confirmation.

Local anesthetic may spread to surrounding tissues, and more than one structure may contribute to the symptoms.

The response should be interpreted alongside the physical examination and overall clinical findings.

Ultrasound guidance can improve visualization of anatomical landmarks and help guide medication placement.

However, landmark-guided techniques have also been described.

The available evidence does not establish that ultrasound guidance is mandatory in every case or that one technique is consistently superior for all patients.

Some patients experience prolonged improvement, but permanent relief cannot be guaranteed.

The injection may reduce nerve irritation and provide a valuable opportunity for rehabilitation.

Patients with persistent mechanical entrapment may require additional treatment.

Superior cluneal nerve entrapment can occur on one or both sides.

If bilateral symptoms and examination findings suggest involvement of the superior cluneal nerves, the physician may consider evaluating both sides.

The decision to perform bilateral injections depends on the clinical situation and procedural considerations.

It may help patients whose symptoms resemble sciatica but actually originate from superior cluneal nerve irritation.

However, it does not directly treat compression of a lumbar spinal nerve root.

Patients with significant leg weakness, progressive neurological symptoms, or suspected nerve root compression require appropriate evaluation.

Although superior cluneal nerve entrapment can cause considerable discomfort, certain symptoms suggest a potentially more serious underlying condition.

Patients should seek urgent medical evaluation if low back pain is accompanied by new bladder or bowel dysfunction, numbness around the groin or saddle region, or rapidly progressive leg weakness.

Fever, unexplained weight loss, significant trauma, or a history of cancer may also warrant prompt investigation, depending on the clinical circumstances.

These symptoms should not be attributed to superior cluneal nerve entrapment without an appropriate medical assessment.

A superior cluneal nerve block can be a useful option for patients with chronic low back pain when the symptoms and physical examination suggest irritation or entrapment of the superior cluneal nerve.

Its greatest value may be the ability to identify a pain source that is frequently missed during routine evaluations.

For some patients, the injection provides meaningful pain relief. For others, the improvement lasts only a few hours or days, but that temporary response can still help guide the next stage of treatment.

If pain returns, options may include rehabilitation, repeat injections, radiofrequency treatment, peripheral nerve stimulation, or surgical decompression in carefully selected cases.

The key is recognizing that a successful superior cluneal nerve block is not necessarily the end of treatment. It may be the first step toward identifying the true cause of persistent low back pain and developing a more targeted management plan.

For patients whose lower back pain remains unexplained despite imaging, medication, and physical therapy, evaluation for superior cluneal nerve entrapment may be worthwhile.

References: